Nexleaf’s ColdTrace innovation has been selected as one of seven Gavi INFUSE Pacesetters that will work with Gavi in its mission to increase access to immunization around the world. With its INFUSE initiative, Gavi seeks to identify the most promising technologies that improve vaccine access and efficacy in low-income countries, with particular emphasis on data-driven innovations. 60 companies and entrepreneurs applied to the program after it was announced at this year’s World Economic Forum; 18 projects were selected for a final round of pitching to evaluators from both private companies and international organizations like the World Health Organization (WHO) and UNICEF. The panel chose seven Pacesetters that will work with Gavi on scaling up their work and serving more countries.
Learn more about INFUSE Pacesetters from The Verge, and read more about ColdTrace here.